These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3718856)

  • 1. Relative potencies of topical steroids.
    Gibson JR; Kirsch JM
    Br J Dermatol; 1986 May; 114(5):638-9. PubMed ID: 3718856
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative potencies of topical corticosteroid formulations.
    Haigh JM; Kanfer I; Meyer E; Smith E
    Br J Dermatol; 1985 Oct; 113(4):502-3. PubMed ID: 4063187
    [No Abstract]   [Full Text] [Related]  

  • 3. An attempt to evaluate the relative clinical potencies of various diluted and undiluted proprietary corticosteroid preparations.
    Gibson JR; Kirsch J; Darley CR; Burke CA
    Clin Exp Dermatol; 1983 Sep; 8(5):489-93. PubMed ID: 6641007
    [No Abstract]   [Full Text] [Related]  

  • 4. The human skin blanching assay--use and abuse.
    Gaylarde PM
    Br J Dermatol; 1986 May; 114(5):636-8. PubMed ID: 3718855
    [No Abstract]   [Full Text] [Related]  

  • 5. The dilution of proprietary corticosteroid ointments--an attempt to evaluate relative clinical potencies.
    Gibson JR; Darley C; Kirsch J; Saihan EM; Neild VS
    Br J Dermatol; 1982 Apr; 106(4):445-7. PubMed ID: 7073968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic topical corticosteroids.
    Med Lett Drugs Ther; 1988 May; 30(765):49-50. PubMed ID: 3362092
    [No Abstract]   [Full Text] [Related]  

  • 7. Reflectance spectrophotometric quantification of skin colour changes induced by topical corticosteroid preparations.
    Feather JW; Ryatt KS; Dawson JB; Cotterill JA; Barker DJ; Ellis DJ
    Br J Dermatol; 1982 Apr; 106(4):437-43. PubMed ID: 7073967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid-induced vasoconstriction in human skin. An inhibitory role on phospholipase A2 activity.
    Marks R; Sawyer M
    Arch Dermatol; 1986 Aug; 122(8):881-3. PubMed ID: 2874773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chamber vasoconstrictor assay. I. Comparison with occluded and unoccluded tests using four corticosteroids.
    Somerma S
    Clin Exp Dermatol; 1980 Jun; 5(2):191-6. PubMed ID: 7438514
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. IV. Time slope of vasoconstriction and reactive vasodilatation (author's transl)].
    Altmeyer P; Zaun H
    Arch Dermatol Res (1975); 1976 Mar; 255(1):43-50. PubMed ID: 1259465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the vasoconstriction assay and clinical activity in psoriasis.
    Cornell RC; Stoughton RB
    Arch Dermatol; 1985 Jan; 121(1):63-7. PubMed ID: 3881088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An attempt to evaluate the relative clinical potencies of various diluted and undiluted proprietary corticosteroid preparations.
    Gibson JR; Kirsch J; Darley CR; Burke CA
    Br J Dermatol; 1983 Jul; 109 Suppl 25():114-6. PubMed ID: 6860578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human vasoconstrictor assay for topical steroids.
    Clanachan I; Devitt HG; Foreman MI; Kelly IP
    J Pharmacol Methods; 1980 Nov; 4(3):209-20. PubMed ID: 7442265
    [No Abstract]   [Full Text] [Related]  

  • 14. An assessment of the relationship between vasoconstrictor assay findings, clinical efficacy and skin thinning effects of a variety of undiluted and diluted corticosteroid preparations.
    Gibson JR; Kirsch JM; Darley CR; Harvey SG; Burke CA; Hanson ME
    Br J Dermatol; 1984 Jul; 111 Suppl 27():204-12. PubMed ID: 6378245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of corticosteroid-induced skin vasoconstriction: visual ranking, chromameter measurement or digital imaging analysis.
    Smith EW; Haigh JM; Surber C
    Dermatology; 2002; 205(1):3-10. PubMed ID: 12145427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroids in dermatology.
    Miller JA; Levene GM
    Br J Hosp Med; 1982 Oct; 28(4):331-2, 337-8. PubMed ID: 6291678
    [No Abstract]   [Full Text] [Related]  

  • 17. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)].
    Zaun H; Altmeyer P
    Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633
    [No Abstract]   [Full Text] [Related]  

  • 18. RU 486 inhibits peripheral effects of glucocorticoids in humans.
    Gaillard RC; Poffet D; Riondel AM; Saurat JH
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1009-11. PubMed ID: 4055982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cutaneous vasoconstriction test in man as a means of evaluating topical corticoids. II. Cutaneous vasoconstrictive effects of topical corticoids in tests devised by various investigators (author's transl)].
    Lutz U; Weirich EG
    Dermatologica; 1974; 148(3):160-74. PubMed ID: 4836957
    [No Abstract]   [Full Text] [Related]  

  • 20. [Telethermography, a new method in the evaluation of topical corticosteroid activity].
    Ippolito F; Di Carlo A
    G Ital Dermatol Venereol; 1988 Jun; 123(6):291-5. PubMed ID: 3215671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.